ANAB

AnaptysBio Inc

May 18 • 04:00PM ET

58.74

-4.41 -6.98 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: MLTX XNCR KYMR IMVT NRIX ARVN

| Held by: VTI XBI IWM VXF IBB BRES IWO FYC VTWO SCHA

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.08	Insider Own	6.56%	Shs Outstand	29.03M	Perf Week	-13.52%
Market Cap	1.71B	Forward P/E	-	EPS next Y	-2.34	Insider Trans	-9.25%	Shs Float	27.19M	Perf Month	30.53%
Enterprise Value	1.70B	PEG	-	EPS next Q	-0.35	Inst Own	99.40%	Short Float	16.41%	Perf Quarter	64.12%
Income	-26.79M	P/S	7.36	EPS this Y	-563.84%	Inst Trans	-5.81%	Short Ratio	5.40	Perf Half Y	164.95%
Sales	232.39M	P/B	133.78	EPS next Y	-15.11%	ROA	-7.13%	Short Interest	4.46M	Perf YTD	81.77%
Book/sh	0.44	P/C	5.97	EPS next 5Y	-	ROE	-114.55%	52W High	72.36 -18.82%	Perf Year	335.82%
Cash/sh	9.84	P/FCF	387.62	EPS past 3/5Y	53.48% 8.82%	ROIC	-9.30%	52W Low	11.40 415.15%	Perf 3Y	365.52%
Dividend Est.	-	EV/EBITDA	39.33	Sales past 3/5Y	183.58% 25.62%	Gross Margin	98.96%	Volatility	8.81% 9.36%	Perf 5Y	259.54%
Dividend TTM	-	EV/Sales	7.32	EPS Y/Y TTM	82.33%	Oper. Margin	17.56%	ATR (14)	4.71	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.58	Sales Y/Y TTM	107.73%	Profit Margin	-11.53%	RSI (14)	49.20	Recom	1.09
Dividend Gr. 3/5Y	- -	Current Ratio	7.58	EPS Q/Q	-43.62%	SMA20	-7.21%	Beta	0.93	Target Price	71.00
Payout	-	Debt/Eq	21.75	Sales Q/Q	-7.98%	SMA50	15.24%	Rel Volume	0.65	Prev Close	63.15
Employees	104	LT Debt/Eq	21.59	Earnings	May 12 AMC	SMA200	86.68%	Avg Volume	826.09K	Price	58.74
IPO	Jan 26, 2017	Option/Short	Yes / Yes	EPS/Sales Surpr.	-185.89% 35.48%	Trades		Volume	535,023	Change	-6.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)